Skip to content

Laser Acupuncture and Pain Management in Preterm Infants Undergoing Patent Ductus Arteriosus Ligation

Laser Acupuncture and Pain Management in Preterm Infants Undergoing Patent Ductus Arteriosus Ligation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02147717
Acronym
ELAPPS
Enrollment
40
Registered
2014-05-28
Start date
2014-05-31
Completion date
2017-05-31
Last updated
2017-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Newborns

Keywords

preterm newborns, Transfontanellar ultrafast doppler, Acupuncture, perioperative pain, surgery of the ductus arteriosus

Brief summary

Prospective study, controlled, randomized, single-center, blinded, which aims to evaluate the effect of laser acupuncture in the treatment of perioperative pain during tracheal suction after patent ductus arteriosus ligation in preterm infants.

Detailed description

management of pain in preterm infants is essential because it is exposed to repetitive movements painful and invasive miners such as surgical treatment of the ductus arteriosus which is accompanied by respiratory instability, increased consumption analgesics. Acupuncture has shown its analgesic efficacy in numerous studies in children and adults. Acupuncture (laser) is a simple, fast method without side effect used in children, but no study exists on the effect of acupuncture in the treatment of perioperative pain in addition to pharmacologic agents in preterm infants. Hypothesis: acupuncture reduce pain and discomfort after surgery of the ductus arteriosus in preterm infants in addition to pharmacologic agents Main objective: Assessing the contribution of laser acupuncture on the pain management during endotracheal suctioning (ETS) after surgery ductus arteriosus in preterm infants

Interventions

Infants will be divided in 2 groups: * Placebo group: Placebo (fake laser stimulation) plus opioid treatment before ETS * Experimental group: Laser stimulation plus opioid treatment before ETS. Low level laser acupuncture, 670 nm, 10Hz, 0,3 J per acupoint, 6 points per neonate (Zu san li, He Gu, Nei Guan) marquage CE, premio 30 laser duo de Sedatelec. Overall 3 minutes of treatment. This sequence will be repeated 4 times during the study (1 hour before surgery and every 12 hours after surgery)

DEVICEFake laser stimulation

newborns have the same preparation procedure as the intervention to put them under the same conditions group. The laser pen is turned off, off-voltage

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
24 Weeks to 32 Weeks
Healthy volunteers
No

Inclusion criteria

* Preterm infant born between 24 +0 and 32 +6 j GA * Ductus arteriosus surgery scheduled in Robert Debré hospital * Informed consent of the holders of the exercise of parental authority * Child beneficiary of a social security scheme (excluding AME)

Exclusion criteria

* Obvious underlying disease (genetic, metabolic)

Design outcomes

Primary

MeasureTime frameDescription
Behavioral pain scale (COMFORT scale)48 hours post-operativeBehavioral pain scale (COMFORT scale) studied at a painful procedure (endotracheal suctioning, ETS) with a regular assessment in perioperative. All the ETS will videotaped with a color digital camera by the research assistant.

Secondary

MeasureTime frameDescription
Behavioral pain scale (DAN scale and EDIN scale)48hours postoperativeBehavioral pain scale during ETS (DAN scale) and after ETS (EDIN scale)
Consumption of morphine48 hours postoperativeConsumption of morphine (cumulative mg / kg dose) from surgery to 48h postoperative
Measurement of FIO248 hours postoperativeMeasurement of FIO2, mode of mechanical ventilation after surgery

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026